Quantcast

Latest Prostate cancer Stories

2014-05-08 16:26:08

CHARLOTTE, N.C., May 8, 2014 /PRNewswire/ -- SonaCare Medical, LLC, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, today announced that the U.S. Food and Drug Administration (FDA) has tentatively scheduled a Gastroenterology and Urology Devices Advisory Committee Panel meeting on October 2, 2014 to review the Company's Premarket Approval (PMA) application for Sonablate® 450 for the treatment of recurrent prostate cancer following external beam...

2014-05-08 08:33:07

Clinicians detail how the Edge(TM) radiosurgery suite and other cancer treatment technologies from Varian Medical Systems are enabling fast, precise tumor targeting MINNEAPOLIS, May 8, 2014 /PRNewswire/ -- Radiation oncologists and a neurosurgeon from noted institutions in the U.S. and Europe report that they are able to use non-invasive radiosurgery to treat a widening variety of cancers due to technology advances that are making it possible to deliver these treatments more quickly...

2014-05-08 08:32:48

SAN DIEGO, May 8, 2014 /PRNewswire/ -- GenomeDx Biosciences announced today that the company's Decipher® Prostate Cancer Classifier will be featured in multiple sessions during the American Urological Association (AUA) Annual Meeting taking place May 16-21 in Orlando, FL. Two data presentations will detail validation studies supporting the use of Decipher to predict risk of metastasis in men following prostate surgery. Decipher has also been included in independent CME and educational...

2014-05-07 23:09:14

Survey results published today, by a Tampa Bay medical device manufacturer, BioDerm, reveal a surprising connection between music and patient’s perceptions of the side effects of prostate cancer treatment. Largo, FL (PRWEB) May 07, 2014 In a survey of more than 200 men with prostate cancer and their caregivers, BioDerm found that opera fans were more than 40% more likely than non-opera fans to report that their side effects after prostate cancer treatment were “worse” or “much...

2014-05-07 23:00:21

Mega car, truck and motorcycle show will raise funds for the Man Up Mahoning Valley Campaign to increase prostate cancer awareness and provide screenings. The event will be held Sunday, June 1, at Boardman High School in Boardman, Ohio. The event is presented by the HMHP Foundation in partnership with Sweeney Chevrolet, Buick, GMC. Boardman, OH (PRWEB) May 08, 2014 The HMHP Foundation is partnering with Sweeney Chevrolet, Buick, GMC to present the second annual Fuel the Fight: Drive Out...

2014-05-06 23:10:10

At Comprehensive Urology in Beverly Hills, urologists perform robotic-assisted prostate surgery, a method which has been shown to be more effective when treating prostate cancer. Beverly Hills, CA (PRWEB) May 06, 2014 A recent study from UCLA has found that robotic-assisted prostatectomy offers a number of advantages over traditional prostatectomy procedures. These benefits include a lower likelihood of patients needing additional treatment and fewer side effects than other prostate...

2014-05-06 16:32:54

13% Increase in Test Volume and 7% Increase in Product Revenue Compared to Prior Year REDWOOD CITY, Calif., May 6, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2014. Logo - http://photos.prnewswire.com/prnh/20130425/SF01493LOGO Product revenue was $67.0 million in the first quarter of 2014, compared with $62.7 million for the first quarter of 2013, an increase of 7 percent. Total revenue for...

2014-05-06 16:29:13

LONDON, May 6, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapieshttp://www.reportbuyer.com/pharma_healthcare/diseases/solid_tumors_market_asia_pacific_2019_new_drug_approvals_anticipated_product_launches_trigger_shift_treatment_paradigm_targeted_therapies.htmlSolid Tumors Market in Asia Pacific to...

2014-05-06 08:35:05

New Prognostic Biopsy Test Is Designed To Guide Individual Treatment Decisions About Prostate Cancer CAMBRIDGE, Mass., May 6, 2014 /PRNewswire/ -- Metamark Genetics, Inc. today announced that it has initiated clinical use of the company's ProMark(TM) prognostic test to help guide the medical management of patients with early-stage prostate cancer. ProMark(TM) is the first and only proteomic multiplex assay for intact biopsy tissue to assess the potential aggressiveness of...

2014-05-06 08:33:30

TOKYO and SAN FRANCISCO, May 6, 2014 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) and Medivation Inc. (NASDAQ: MDVN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the supplemental New Drug Application (sNDA) to extend the indication for XTANDI® (enzalutamide) capsules for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) who have not received chemotherapy. This sNDA application was granted Priority Review...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.